Home | Welcome to Contract Pharma   
Last Updated Monday, March 30 2015

Print

Search Results for 'Biogen Acquires Full Tysabri Rights'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 12, 2014
Rudick bring expertise in MS programs Read More »
Published February 6, 2013
Elan to receive $3.25 billion, royalties Read More »
Complying with Track and Trace
By Stephen Barlas
Published April 30, 2008
Biogen Idec blazes a path to California compliance Read More »
Published February 15, 2007
Biogen Idec 4Q Revenues: $708 million (+12%) 4Q Earnings: $109 million (+95%) FY Revenues: $2.68 billion (+11%) FY Earnings: $218 million (+35%) Comments: Revenues for the quarter and FY2006 included $218 million and $811 million,… Read More »
The Top 50 Biopharma Products
By Ronald A. Rader
Published July 14, 2011
A list of the best-selling biopharma products from 2010 Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On